CN113476382A - 一种含有海盐竹炭的净螨温和氨基酸洁面皂 - Google Patents
一种含有海盐竹炭的净螨温和氨基酸洁面皂 Download PDFInfo
- Publication number
- CN113476382A CN113476382A CN202110821490.1A CN202110821490A CN113476382A CN 113476382 A CN113476382 A CN 113476382A CN 202110821490 A CN202110821490 A CN 202110821490A CN 113476382 A CN113476382 A CN 113476382A
- Authority
- CN
- China
- Prior art keywords
- mite
- sea salt
- bamboo charcoal
- amino acid
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 title claims abstract description 29
- 239000011780 sodium chloride Substances 0.000 title claims abstract description 29
- 235000002639 sodium chloride Nutrition 0.000 title claims abstract description 29
- 239000003610 charcoal Substances 0.000 title claims abstract description 27
- 235000017166 Bambusa arundinacea Nutrition 0.000 title claims abstract description 26
- 235000017491 Bambusa tulda Nutrition 0.000 title claims abstract description 26
- 241001330002 Bambuseae Species 0.000 title claims abstract description 26
- 235000015334 Phyllostachys viridis Nutrition 0.000 title claims abstract description 26
- 239000011425 bamboo Substances 0.000 title claims abstract description 26
- 239000000344 soap Substances 0.000 title claims abstract description 25
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 16
- 230000001815 facial effect Effects 0.000 title claims description 23
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 239000003814 drug Substances 0.000 claims abstract description 21
- 238000004140 cleaning Methods 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 6
- 241000736299 Adiantum Species 0.000 claims description 6
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 6
- 235000019864 coconut oil Nutrition 0.000 claims description 6
- 239000003240 coconut oil Substances 0.000 claims description 6
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 6
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 6
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 6
- 229940079776 sodium cocoyl isethionate Drugs 0.000 claims description 6
- 229940045944 sodium lauroyl glutamate Drugs 0.000 claims description 6
- IWIUXJGIDSGWDN-UQKRIMTDSA-M sodium;(2s)-2-(dodecanoylamino)pentanedioate;hydron Chemical compound [Na+].CCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O IWIUXJGIDSGWDN-UQKRIMTDSA-M 0.000 claims description 6
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 5
- 229920000881 Modified starch Polymers 0.000 claims description 5
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 238000007599 discharging Methods 0.000 claims description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 3
- -1 octyl glycol Chemical compound 0.000 claims description 3
- 238000005070 sampling Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 241000244987 Daiswa polyphylla Species 0.000 claims description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 2
- 241000334154 Isatis tinctoria Species 0.000 claims description 2
- 241000913745 Spatholobus Species 0.000 claims description 2
- 240000001949 Taraxacum officinale Species 0.000 claims description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 2
- 235000011477 liquorice Nutrition 0.000 claims description 2
- 229940092258 rosemary extract Drugs 0.000 claims description 2
- 235000020748 rosemary extract Nutrition 0.000 claims description 2
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 2
- 239000000341 volatile oil Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 25
- 206010000496 acne Diseases 0.000 abstract description 24
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 20
- 241000238876 Acari Species 0.000 abstract description 17
- 208000003251 Pruritus Diseases 0.000 abstract description 6
- 230000002087 whitening effect Effects 0.000 abstract description 5
- 230000007803 itching Effects 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 4
- 230000001954 sterilising effect Effects 0.000 abstract description 4
- 230000002195 synergetic effect Effects 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 102000003425 Tyrosinase Human genes 0.000 abstract description 2
- 108060008724 Tyrosinase Proteins 0.000 abstract description 2
- 239000003463 adsorbent Substances 0.000 abstract description 2
- 239000003205 fragrance Substances 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract description 2
- 230000036407 pain Effects 0.000 abstract description 2
- 230000008961 swelling Effects 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000002000 scavenging effect Effects 0.000 abstract 1
- 238000004659 sterilization and disinfection Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 26
- 239000003921 oil Substances 0.000 description 16
- 235000019198 oils Nutrition 0.000 description 16
- 238000011156 evaluation Methods 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 8
- 208000020154 Acnes Diseases 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000013543 active substance Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000004519 grease Substances 0.000 description 4
- 210000001732 sebaceous gland Anatomy 0.000 description 4
- 239000002390 adhesive tape Substances 0.000 description 3
- 210000004209 hair Anatomy 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 241000746375 Andrographis Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 206010016936 Folliculitis Diseases 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- 241001310146 Ilex cornuta Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 241000212749 Zesius chrysomallus Species 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000006355 external stress Effects 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940068797 tribulus terrestris extract Drugs 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
本发明公开了一种含有海盐竹炭的净螨温和氨基酸洁面皂及制备方法。该洁面皂含有的除螨中药组合物会散发一种强效除螨功效的特殊香味吸引螨虫聚集而杀之,而且还具有良好的清除自由基、抑制酪氨酸酶活性作用,具有一定的抗衰老和美白功能。含有来自死海的海盐具有促进肌体血液循环、杀菌止痒、消肿止痛、美白去角质、粉刺、黑头的作用。含有的纳米级竹炭是一种强效吸附剂,能吸附皮肤深层的污垢和螨虫。通过本发明组分间的协同增效,表现出强效控油、杀菌、除螨、祛痘效果。
Description
技术领域
本发明属于日化领域,具体地涉及一种含有海盐竹炭的净螨温和氨基酸洁面皂及制备方法。
背景技术
痘是痤疮的俗称,又叫“青春痘”、“暗疮”或“粉刺”,是由于毛囊及皮脂腺阻塞、发炎所引发的一种皮肤病。痘的产生主要原因主要有如下几个方面:
青春期时,体内过剩的荷尔蒙会刺激毛发快速生长,皮脂腺分泌更多油脂,毛发和皮脂腺因此堆积过多物质,使油脂和细菌更易附着,引发皮肤红肿的反应。由于这种症状常见于青年男女,所以才称它为“青春痘”。祛痘是运用医学技术或方法消除青春痘的过程。
人体皮肤螨虫与人体面部出现的问题:如毛囊炎,脂溢性皮炎,脱发,睑缘炎,外耳道瘙痒等,特别是与痤疮,酒渣鼻的发生关系十分密切。螨虫多寄生于毛囊皮脂腺内,吸取细胞内营养物质,和皮脂腺分泌物,而破损正常细胞;并由于虫体的机械刺激和虫体排泄物的化学性刺激作用,寄生部位可引起毛囊扩大、血管扩张周围细胞浸润、纤维组织增生,而使组织损坏,引起过敏反应,皮肤出现红色斑、丘疹、肉芽肿、脓疱和瘙痒等现象。
科学的祛痘途径应该是从控制皮肤油脂分泌、清除皮肤螨虫、清洁皮肤和减少皮肤刺激等方面进行综合护肤。
目前,祛痘活性物多为化学合成物质,有的甚至采用杀虫剂和硫磺等作为活性物,但杀虫剂毒害性大,硫磺气味大。为了克服化学合成物质的缺陷,采用天然活性物来除螨祛痘已经成为了研究热点。
本发明就是为了满足人民对皮肤控油祛痘除螨而研制的洁面皂,具有强效除螨和控油、祛痘、止痒、舒缓皮肤等多种功效,而且温和无刺激。
发明内容
本发明的目的就是为了克服目前控油祛痘除螨剂的缺陷,提供一种含有海盐竹炭的净螨温和氨基酸洁面皂,其采用纯天然的植物提取物达到强效除螨和控油、祛痘、止痒、舒缓皮肤功效,且温和无刺激。
为了达到上述发明目的,本发明采取了如下技术方案﹕
一种含有海盐竹炭的净螨温和氨基酸洁面皂,由改性玉米淀粉、聚乙烯吡咯烷酮、月桂酰谷氨酸钠、甘油、椰油酰羟乙磺酸酯钠、椰油酸、海藻糖、柠檬酸、猴面包树籽油、辛甘醇、对羟基苯乙酮、海盐、玉米淀粉、聚乙烯吡咯烷酮、月桂酰谷氨酸钠、甘油、椰油酰羟乙磺酸酯钠、椰油酸、海藻糖、柠檬酸、猴面包树籽油、辛甘醇、对羟基苯乙酮、海盐、除螨中药组合物、1,2-己二醇、炭粉、精油、去离子水组成。
所述的一种含有海盐竹炭的净螨温和氨基酸洁面皂,其各组分质量分数分别为:
优选的,所述的一种含有海盐竹炭的净螨温和氨基酸洁面皂,其各组分质量分数分别为:
优选的,所述的一种含有海盐竹炭的净螨温和氨基酸洁面皂,其各组分质量分数分别为:
所述的除螨中药组合物由菘蓝提取物、甘草提取物、迷迭香提取物、七叶一枝花提取物、鸡血藤提取物、欧蒲公英根茎/根提取物组成。
所述的祛痘中药组合物由金银花提取液、枇杷叶提取液、连翘提取液、黄芩提取液、四季青提取液、穿心莲提取液、刺蒺藜提取液、桑白皮提取液组成。
为了制备出上述洁面皂,本发明采用了如下制备方法:
①将原料中粉末物质用200目筛网过筛待用;
②把改性玉米淀粉、聚乙烯吡咯烷酮加入混合机中搅拌10分钟预先混匀备用,为A相;
③把月桂酰谷氨酸钠、椰油酰羟乙磺酸酯钠、椰油酸、海藻糖依次投入加入A相混合机中,搅拌完全至粉末均匀;
④将甘油、辛甘醇、对羟基苯乙酮、海盐中的原料预先混合分散均匀,然后缓慢倒入混合机中,搅拌30分钟;
⑤将猴面包树籽油、1,2-己二醇、除螨中药组合物依次加入混合机中,充分搅拌分散均匀;
⑥将炭粉和去离子水预先分散好,加入混合搅拌至颜色均匀;
⑦加入香精,搅拌均匀;
⑧取样送检合格后出料。
本发明相对于现有技术具有如下的优点及效果:
(1)本发明的中药提取物会散发一种特殊的香味,能将使用部位周围螨虫吸引过来,一方面,中药组合物活性物能将螨虫的脑神经先麻醉,再刺激脑细胞直至各神经断开,让螨虫进入深度“睡眠”状态,防止螨虫交配与繁殖;而且这些中药提取物组合物具有强效杀灭螨虫功效。多方面协同增效清除螨虫,消除螨虫这种致敏原而具有止痒功效。除了控油、杀菌、除螨、祛痘效果外,上述中药组合物,还具有良好的清除自由基、抑制酪氨酸酶活性作用,具有一定的抗衰老和美白功能。
(2)本发明的竹炭粉为纳米活性炭,比表面积大、化学稳定性高、孔隙结构发达、表面活性独特,是一种优良的吸附剂;同时,纳米活性炭还具有选择性高、毒副作用低、生物相容性好等特点,因而近年来常被用做药物缓释材料。纳米竹炭含有丰富的-OH、-COOH等不同种类的含氧官能团,是其主要活性位,这些活性位点使得纳米竹炭表面呈现微弱的亲水性、氧化性和酸性等性质。植物提取物中通常含有-NH、-CO-、-OH等极性很强的官能团,能被纳米竹炭中的活性位点吸附。从而能“抓住”体系中功效活性因子,缓释到皮肤中,达到助力活性成分吸收的目的,而且有助于深层螨虫的清除。
(3)本发明的海盐是死海的海盐,含有丰富的氯化镁、钠、钾、钙、溴和其他矿物质,具有促进肌体血液循环,增强肌体外界的抗压力。并可杀菌止痒、消肿止痛、美白去角质、粉刺、黑头的作用,还可以防止皮肤病传播还能够帮助人体改善皮肤缓解疲劳和肌肉酸痛等,可清除皮肤角质层,延缓皮肤衰老,健美皮肤,使皮肤细腻光滑可促进皮肤血液循环,有效除去皮肤死亡细胞,改善皮肤粗糙,滋润嫩白肌肤使面部皮肤光泽,柔润,有透明感。特别是有辅助清除螨虫的效果。
具体实施方式
下面结合实施例对本发明作进一步详细的描述,但本发明的实施方式不限于此。
下列实施例中未注明具体实验条件的试验方法,通常按照常规实验条件或按照制造厂所建议的实验条件。
实施例1-3含有海盐竹炭的净螨温和氨基酸洁面皂
实施例1-3的含有海盐竹炭的净螨温和氨基酸洁面皂配方如表1所示,用量以质量分数计。
表1
制备方法如下:
①将原料中粉末物质用200目筛网过筛待用;
②把改性玉米淀粉、聚乙烯吡咯烷酮加入混合机中搅拌10分钟预先混匀备用,为A相;
③把月桂酰谷氨酸钠、椰油酰羟乙磺酸酯钠、椰油酸、海藻糖依次投入加入A相混合机中,搅拌完全至粉末均匀;
④将甘油、辛甘醇、对羟基苯乙酮、海盐中的原料预先混合分散均匀,然后缓慢倒入混合机中,搅拌30分钟;
⑤将猴面包树籽油、1,2-己二醇、除螨中药组合物依次加入混合机中,充分搅拌分散均匀;
⑥将炭粉和去离子水预先分散好,加入混合搅拌至颜色均匀;
⑦加入香精,搅拌均匀;
⑧取样送检合格后出料。
对比例1
除螨中药组合物质量分数为1.0%,海盐质量分数为0,竹炭粉质量分数为1.0%,其余成分与实施例1一致。
对比例2
除螨中药组合物质量分数为0,海盐质量分数为1.0%,竹炭粉质量分数为1.0%,其余成分与实施例1一致。
对比例3
除螨中药组合物质量分数为0.5%,海盐质量分数为2.0%,竹炭粉质量分数为0,其余成分与实施例1一致。
对比例4
除螨中药组合物质量分数为0.5%,海盐质量分数为0,竹炭粉质量分数为2%,其余成分与实施例1一致。
实验例1除螨效果评价
按照NY/T1151.2-2006《农药登记卫生用杀虫剂室内药效试验方法及评价第2部分:灭螨和驱螨剂》和GB/T 24253-2009《纺织品防螨性能的评价》进行了除螨效果试验,结果见表2所示。
表2
表2结果表明,本发明的洁面皂除螨效果非常显著。而且比对比例效果好,说明除螨中药组合物与祛痘中药组合物复配有协同增效除螨的作用。
实验例2控油功效评价实验
1、试验原理
采用油脂测试仪SebumeterSM815测试皮肤的油脂含量。它是基于光度计原理,一种0.1mm厚的特殊消光胶带吸收人体皮肤上的油脂后,就会变成一种半透明的胶带,它的透光量就会发生变化,吸收的油脂越多,透光量就会越大,这样就可以测量出皮肤油脂的含量。
2、试验仪器:
SebumeterSM815(德国Courage+Khazaha公司)
3、试验样品
实施例1-3制备的洁面皂。
4、试验方法
油性头皮受试者30名。受试者在温度22±3℃,相对湿度50±5%的实验室内静坐30分钟,用油脂测试仪SebumeterSM815分别测试左右额头的皮肤油脂含量,记为D0的数据,将样品分发给每个受试者,每天沐浴一次,持续28天,并分别在第14天和第28天回恒温实验室测试皮肤油脂含量,数据记为D14和D28。按如下公式分别计算出D14和D28的油脂含量变化率:
油脂含量变化率={(使用样品后油脂含量-使用样品前油脂含量)/使用样品前油脂含量}×100%
5、实验结果:
结果如表3所示。
表3
测试样品 | D14油脂变化率(%) | D28油脂变化率(%) |
实施例1 | -22.2% | -34.7% |
实施例2 | -24.3% | -35.8% |
实施例3 | -26.8% | -37.9% |
对比例1 | -17.6% | -25.7% |
对比例2 | -17.4% | -24.9% |
对比例3 | -12.1% | -18.6% |
对比例4 | -18.7% | -28.9% |
结果显示,本发明洁面皂具有良好的控油效果。而且比对比例效果好,说明除螨中药组合物与祛痘中药组合物复配有协同增效控油的作用。
实验例4祛痘效果评价
评价样品:实施例1制备的洁面皂
评价对象﹕选择面部有痤疮、年龄为15-30岁的年轻人60例,其中男性20例,女性40例。
评价方法﹕采用双盲法,每天早晚涂擦实施例4制备除螨祛痘精华液,30天为一个疗程。
评价标准﹕①显效﹕痤疮消褪70%以上;②有效﹕痤疮消褪30%以上;③无效﹕痤疮消褪30%以下。
评价结果﹕见表5所示。
表5
组别 | 显效率/% | 有效率/% | 无效率/% | 总有效率/% |
实施例1 | 63.3 | 28.3 | 8.4 | 91.6 |
结果显示,本发明洁面皂具有良好的祛痘效果。
实验例5使用效果评价
将实施例1产品随机发给300名试用者,各发5瓶,由试用者回家使用,使用1个月后由试用者填写和反馈使用报告。
统计结果表明,超过90%的试用者认为本发明洁面皂温和无刺激,具有良好的控油、祛痘、止痒、舒缓皮肤效果,特别使用后肌肤光滑、丰盈细腻、弹性好,倍感清新舒爽。
以上对本发明的具体实施例进行了详细描述,但其只是作为范例,本发明并不限制于以上描述的具体实施例。对于本领域技术人员而言,任何对本发明进行的等同修改和替代也都在本发明的范畴之中。因此,在不脱离本发明的精神和范围下所作的均等变换和修改,都应涵盖在本发明的范围内。
Claims (5)
1.一种含有海盐竹炭的净螨温和氨基酸洁面皂,其特征在于,改性玉米淀粉、聚乙烯吡咯烷酮、月桂酰谷氨酸钠、甘油、椰油酰羟乙磺酸酯钠、椰油酸、海藻糖、柠檬酸、猴面包树籽油、辛甘醇、对羟基苯乙酮、海盐、除螨中药组合物、1,2-己二醇、炭粉、精油、去离子水组成;所述的除螨中药组合物由菘蓝提取物、甘草提取物、迷迭香提取物、七叶一枝花提取物、鸡血藤提取物、欧蒲公英根茎/根提取物组成。
5.根据权利要求1所述的一种含有海盐竹炭的净螨温和氨基酸洁面皂的制备方法,其特征在于,包括以下步骤,
①将原料中粉末物质用200目筛网过筛待用;
②把改性玉米淀粉、聚乙烯吡咯烷酮加入混合机中搅拌10分钟预先混匀备用,为A相;
③把月桂酰谷氨酸钠、椰油酰羟乙磺酸酯钠、椰油酸、海藻糖依次投入加入A相混合机中,搅拌完全至粉末均匀;
④将甘油、辛甘醇、对羟基苯乙酮、海盐中的原料预先混合分散均匀,然后缓慢倒入混合机中,搅拌30分钟;
⑤将猴面包树籽油、1,2-己二醇、除螨中药组合物依次加入混合机中,充分搅拌分散均匀;
⑥将炭粉和去离子水预先分散好,加入混合搅拌至颜色均匀;
⑦加入香精,搅拌均匀;
⑧取样送检合格后出料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110821490.1A CN113476382A (zh) | 2021-07-20 | 2021-07-20 | 一种含有海盐竹炭的净螨温和氨基酸洁面皂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110821490.1A CN113476382A (zh) | 2021-07-20 | 2021-07-20 | 一种含有海盐竹炭的净螨温和氨基酸洁面皂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113476382A true CN113476382A (zh) | 2021-10-08 |
Family
ID=77941651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110821490.1A Pending CN113476382A (zh) | 2021-07-20 | 2021-07-20 | 一种含有海盐竹炭的净螨温和氨基酸洁面皂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113476382A (zh) |
-
2021
- 2021-07-20 CN CN202110821490.1A patent/CN113476382A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5554361A (en) | Processed product for skin and hair treatment | |
CN102342993B (zh) | 一种皮肤抗敏修复外用制剂 | |
CN103520053B (zh) | 洗发沐浴粉 | |
JP2021050249A (ja) | ザクロ種子油、rosa canina果実油、およびinula viscosa含油樹脂または抽出物を含有する製剤 | |
KR20090129490A (ko) | 호로파 추출물 | |
BRPI0318498B1 (pt) | composições terapêuticas à base de porifera para o tratamento e a prevenção de doenças da pele | |
CN109157451A (zh) | 一种祛痘洁面乳 | |
CN110035797A (zh) | 用于治疗痤疮的局部组合物 | |
CN111714394A (zh) | 一种温和舒缓多效植物除螨清肌沐浴露及制备工艺 | |
CN106726919A (zh) | 一种不含二噁烷的婴幼儿氨基酸草本组合物及其制备 | |
CN105168063A (zh) | 一种具有祛痘功效的护肤组合物及其制备方法 | |
CN113398050A (zh) | 一种清螨控油沐浴露 | |
CN113520964A (zh) | 一种含深海盐的控油祛痘除螨净颜洁面乳 | |
KR20150122983A (ko) | 박하초를 함유하는 화장료 조성물 | |
CN102196813A (zh) | 包含印楝和苦瓜或芝麻的提取物的局部组合物 | |
CN113476382A (zh) | 一种含有海盐竹炭的净螨温和氨基酸洁面皂 | |
JP2005060320A (ja) | 皮膚ダニ駆除剤及びこれを含有する皮膚外用剤 | |
CN110711166A (zh) | 一种控油保湿功效的爽肤水 | |
CN105963243A (zh) | 一种治疗寻常痤疮的龙脑香樟精油缓释乳膏及其制备方法 | |
CN104983817A (zh) | 一种治疗脂溢性脱发的酊剂及其制备方法 | |
CN109431824A (zh) | 一种抗菌除臭凝胶及其应用 | |
CN110934780B (zh) | 一种宠物犬健康护理沐浴液及其制备方法 | |
KR101643241B1 (ko) | 피부 민감용 천연비누 조성물 | |
CA2132170A1 (en) | Medicine for the treatment of alopecia and skin diseases | |
CN111631963A (zh) | 一种控油去屑保湿止痒植物除螨清肌洗发水及制备工艺 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20211008 |
|
WD01 | Invention patent application deemed withdrawn after publication |